Stocktoria
Apyx Medical Corp APYX
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1983-07-22
Apyx Medical Corp statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 62.5% | 61.0% | 64.5% | 65.4% | 69.3% |
| Operating margin | -12.2% | -39.2% | -33.0% | -52.9% | -29.8% |
| Net margin | -21.2% | -48.8% | -35.7% | -52.1% | -31.3% |
| FCF margin | -17.2% | -39.0% | -11.0% | -47.8% | -23.0% |
| Return on assets | -16.8% | -36.2% | -23.6% | -44.8% | -22.1% |
| Return on equity | -75.6% | -163.7% | -69.5% | -61.3% | -28.1% |
| Debt / equity | 2.53× | 2.62× | 1.23× | 0.00× | — |
| Current ratio | 5.00 | 5.26 | 5.52 | 3.63 | 4.60 |
| Revenue growth | 9.9% | -8.1% | 17.6% | -8.3% | 75.1% |
Source: SEC EDGAR filings · CIK 0000719135 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.